In September 2023, Boston-based Dana-Farber Cancer Institute rolled out plans to build a freestanding cancer center with Boston-based Beth Israel Deaconess Medical Center, a move that will end the institute’s existing oncology partnership with Brigham and Women’s Hospital, also in Boston.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
